tiprankstipranks
Trending News
More News >
9 Meters Biopharma (NMTRQ)
OTHER OTC:NMTRQ
US Market

9 Meters Biopharma (NMTRQ) Stock Statistics & Valuation Metrics

Compare
1,963 Followers

Total Valuation

9 Meters Biopharma has a market cap or net worth of $14.00. The enterprise value is ―.
Market Cap$14.00
Enterprise Value

Share Statistics

9 Meters Biopharma has 14,459,690 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,459,690
Owned by Insiders
Owned by Institutions

Financial Efficiency

9 Meters Biopharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count10
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of 9 Meters Biopharma is ―. 9 Meters Biopharma’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, 9 Meters Biopharma had revenue of ― and earned -43.77M in profits. Earnings per share was ―.
Revenue
Gross Profit
Operating Income-42.02M
Pretax Income
Net Income-43.77M
EBITDA-39.30M
Earnings Per Share (EPS)

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share

Dividends & Yields

9 Meters Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta150.70
52-Week Price Change
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)

Important Dates

9 Meters Biopharma upcoming earnings date is May 14, 2024, TBA (Confirmed).
Last Earnings DateMar 20, 2024
Next Earnings DateMay 14, 2024
Ex-Dividend Date

Financial Position

9 Meters Biopharma as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, 9 Meters Biopharma has paid ― in taxes.
Income Tax
Effective Tax Rate

Enterprise Valuation

9 Meters Biopharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

9 Meters Biopharma has ― in cash and marketable securities with 5.17M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities
Total Debt5.17M
Net Cash
Net Cash Per Share
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for 9 Meters Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis